ID   NAPEP_RAT               Reviewed;         396 AA.
AC   Q769K2;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 113.
DE   RecName: Full=N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D;
DE            Short=N-acyl phosphatidylethanolamine phospholipase D;
DE            Short=NAPE-PLD {ECO:0000303|PubMed:16527816};
DE            Short=NAPE-hydrolyzing phospholipase D;
DE            EC=3.1.4.54 {ECO:0000269|PubMed:16527816};
GN   Name=Napepld;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 103-114 AND 368-379,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND FUNCTION.
RX   PubMed=14634025; DOI=10.1074/jbc.m306642200;
RA   Okamoto Y., Morishita J., Tsuboi K., Tonai T., Ueda N.;
RT   "Molecular characterization of a phospholipase D generating anandamide and
RT   its congeners.";
RL   J. Biol. Chem. 279:5298-5305(2004).
RN   [2]
RP   FUNCTION, COFACTOR, ACTIVITY REGULATION, SUBUNIT, POTENTIAL ZINC-BINDING
RP   SITES, AND MUTAGENESIS OF ASP-147; CYS-170; HIS-185; HIS-187; ASP-189;
RP   HIS-190; LEU-207; CYS-222; CYS-224; CYS-237; HIS-253; CYS-255; ASP-284;
RP   CYS-288; HIS-321; HIS-331; HIS-343; HIS-353 AND HIS-380.
RX   PubMed=16527816; DOI=10.1074/jbc.m512359200;
RA   Wang J., Okamoto Y., Morishita J., Tsuboi K., Miyatake A., Ueda N.;
RT   "Functional analysis of the purified anandamide-generating phospholipase D
RT   as a member of the metallo-beta-lactamase family.";
RL   J. Biol. Chem. 281:12325-12335(2006).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY
RP   REGULATION.
RX   PubMed=17655883; DOI=10.1016/j.neuropharm.2007.06.001;
RA   Wang J., Okamoto Y., Tsuboi K., Ueda N.;
RT   "The stimulatory effect of phosphatidylethanolamine on N-
RT   acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD).";
RL   Neuropharmacology 54:8-15(2008).
CC   -!- FUNCTION: D-type phospholipase that hydrolyzes N-acyl-
CC       phosphatidylethanolamines (NAPEs) to produce bioactive N-
CC       acylethanolamines/fatty acid ethanolamides (NAEs/FAEs) and phosphatidic
CC       acid (PubMed:14634025, PubMed:16527816, PubMed:17655883). Cleaves the
CC       terminal phosphodiester bond of diacyl- and alkenylacyl-NAPEs,
CC       primarily playing a role in the generation of long-chain saturated and
CC       monounsaturated NAEs in the brain (By similarity). May control NAPE
CC       homeostasis in dopaminergic neuron membranes and regulate neuron
CC       survival, partly through RAC1 activation (By similarity). As a
CC       regulator of lipid metabolism in the adipose tissue, mediates the
CC       crosstalk between adipocytes, gut microbiota and immune cells to
CC       control body temperature and weight. In particular, regulates energy
CC       homeostasis by promoting cold-induced brown or beige adipocyte
CC       differentiation program to generate heat from fatty acids and glucose.
CC       Has limited D-type phospholipase activity toward N-acyl lyso-NAPEs (By
CC       similarity). {ECO:0000250|UniProtKB:Q8BH82,
CC       ECO:0000269|PubMed:14634025, ECO:0000269|PubMed:16527816,
CC       ECO:0000269|PubMed:17655883}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine = a
CC         1,2-diacyl-sn-glycero-3-phosphate + an N-acylethanolamine + H(+);
CC         Xref=Rhea:RHEA:33159, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52640, ChEBI:CHEBI:58608, ChEBI:CHEBI:62537; EC=3.1.4.54;
CC         Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33160;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-butanoyl-1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphate + H(+) + N-butanoyl
CC         ethanolamine; Xref=Rhea:RHEA:45620, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72860, ChEBI:CHEBI:85298,
CC         ChEBI:CHEBI:85304; Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45621;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-hexanoyl-1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphate + H(+) + N-hexanoyl
CC         ethanolamine; Xref=Rhea:RHEA:45616, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72860, ChEBI:CHEBI:85297,
CC         ChEBI:CHEBI:85303; Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45617;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-octanoyl-1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphate + H(+) + N-octanoyl
CC         ethanolamine; Xref=Rhea:RHEA:45612, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72860, ChEBI:CHEBI:85296,
CC         ChEBI:CHEBI:85302; Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45613;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-decanoyl-1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphate + H(+) + N-decanoyl
CC         ethanolamine; Xref=Rhea:RHEA:45608, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72860, ChEBI:CHEBI:85295,
CC         ChEBI:CHEBI:85301; Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45609;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-dodecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate
CC         + H(+) + N-dodecanoylethanolamine; Xref=Rhea:RHEA:45556,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74546,
CC         ChEBI:CHEBI:85263, ChEBI:CHEBI:85294;
CC         Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45557;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-tetradecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate
CC         + H(+) + N-tetradecanoylethanolamine; Xref=Rhea:RHEA:45552,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74546,
CC         ChEBI:CHEBI:85262, ChEBI:CHEBI:85293;
CC         Evidence={ECO:0000269|PubMed:16527816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45553;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-hexadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate
CC         + H(+) + N-hexadecanoylethanolamine; Xref=Rhea:RHEA:45540,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:71464,
CC         ChEBI:CHEBI:74546, ChEBI:CHEBI:78097;
CC         Evidence={ECO:0000269|PubMed:16527816, ECO:0000269|PubMed:17655883};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45541;
CC         Evidence={ECO:0000305|PubMed:16527816, ECO:0000305|PubMed:17655883};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N,1-dihexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphate + H(+) + N-
CC         hexadecanoylethanolamine; Xref=Rhea:RHEA:45596, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:71464, ChEBI:CHEBI:72860,
CC         ChEBI:CHEBI:85334; Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45597;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-octadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate
CC         + H(+) + N-octadecanoyl ethanolamine; Xref=Rhea:RHEA:45536,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74546,
CC         ChEBI:CHEBI:85292, ChEBI:CHEBI:85299;
CC         Evidence={ECO:0000269|PubMed:16527816, ECO:0000269|PubMed:17655883};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45537;
CC         Evidence={ECO:0000305|PubMed:16527816, ECO:0000305|PubMed:17655883};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N,1,2-tri-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate
CC         + H(+) + N-(9Z-octadecenoyl) ethanolamine; Xref=Rhea:RHEA:45532,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:71466,
CC         ChEBI:CHEBI:74546, ChEBI:CHEBI:85291;
CC         Evidence={ECO:0000269|PubMed:16527816, ECO:0000269|PubMed:17655883};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45533;
CC         Evidence={ECO:0000305|PubMed:16527816, ECO:0000305|PubMed:17655883};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-1,2-diacyl-sn-
CC         glycero-3-phosphoethanolamine = a 1,2-diacyl-sn-glycero-3-phosphate +
CC         H(+) + N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine;
CC         Xref=Rhea:RHEA:56548, ChEBI:CHEBI:2700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58608, ChEBI:CHEBI:140532;
CC         Evidence={ECO:0000250|UniProtKB:Q6IQ20};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56549;
CC         Evidence={ECO:0000250|UniProtKB:Q6IQ20};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphoethanolamine = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + H(+) + N-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-ethanolamine; Xref=Rhea:RHEA:45528,
CC         ChEBI:CHEBI:2700, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:74546, ChEBI:CHEBI:85277;
CC         Evidence={ECO:0000269|PubMed:16527816, ECO:0000269|PubMed:17655883};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45529;
CC         Evidence={ECO:0000305|PubMed:16527816, ECO:0000305|PubMed:17655883};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-N-hexadecanoyl-ethanolamine + H2O = 1-O-(1Z-octadecenoyl)-2-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphate + H(+) + N-
CC         hexadecanoylethanolamine; Xref=Rhea:RHEA:56464, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:71464, ChEBI:CHEBI:138663,
CC         ChEBI:CHEBI:140452; Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56465;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N,1-diacyl-sn-glycero-3-phosphoethanolamine = a 1-acyl-
CC         sn-glycero-3-phosphate + an N-acylethanolamine + H(+);
CC         Xref=Rhea:RHEA:53164, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52640, ChEBI:CHEBI:57970, ChEBI:CHEBI:85216;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53165;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N,1-dihexadecanoyl-sn-glycero-3-phosphoethanolamine = 1-
CC         hexadecanoyl-sn-glycero-3-phosphate + H(+) + N-
CC         hexadecanoylethanolamine; Xref=Rhea:RHEA:45592, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57518, ChEBI:CHEBI:71464,
CC         ChEBI:CHEBI:85335; Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45593;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-1-(9Z-octadecenoyl)-
CC         sn-glycero-3-phosphoethanolamine = 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphate + H(+) + N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine;
CC         Xref=Rhea:RHEA:45544, ChEBI:CHEBI:2700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:74544, ChEBI:CHEBI:85223;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45545;
CC         Evidence={ECO:0000250|UniProtKB:Q8BH82};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000305|PubMed:16527816};
CC       Note=Binds 2 zinc divalent cations per subunit.
CC       {ECO:0000250|UniProtKB:Q6IQ20};
CC   -!- ACTIVITY REGULATION: Activated by divalent cations (PubMed:17655883).
CC       Activated by bile acids (By similarity). Activated by membrane
CC       phospholipids such as phosphatidylethanolamines. Inhibited by
CC       cardiolipins (PubMed:17655883). {ECO:0000250|UniProtKB:Q6IQ20,
CC       ECO:0000269|PubMed:17655883}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4 uM for N-hexadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine (in the presence of calcium ions)
CC         {ECO:0000269|PubMed:17655883};
CC         KM=1.7 uM for N-hexadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine (in the presence of calcium ions and
CC         phosphatidylethanolamine) {ECO:0000269|PubMed:17655883};
CC         Vmax=790.6 nmol/min/mg enzyme toward N-hexadecanoyl-1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphoethanolamine (in the presence of
CC         calcium ions) {ECO:0000269|PubMed:17655883};
CC         Vmax=1263 nmol/min/mg enzyme toward N-hexadecanoyl-1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphoethanolamine (in the presence of
CC         calcium ions and phosphatidylethanolamine)
CC         {ECO:0000269|PubMed:17655883};
CC   -!- SUBUNIT: Homodimer. Bile acids promote the assembly of inactive
CC       monomers into an active dimer and enable catalysis.
CC       {ECO:0000250|UniProtKB:Q6IQ20}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q6IQ20}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q6IQ20}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q6IQ20}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q6IQ20}. Nucleus envelope
CC       {ECO:0000250|UniProtKB:Q6IQ20}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q6IQ20}. Note=Localized in the proximity of the
CC       cellular membranes likely through interaction with membrane
CC       phospholipids. {ECO:0000250|UniProtKB:Q6IQ20}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest expression in brain,
CC       kidney and testis (at protein level). Expressed in adipose tissue (at
CC       protein level). {ECO:0000250|UniProtKB:Q8BH82}.
CC   -!- SIMILARITY: Belongs to the NAPE-PLD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB112351; BAD02398.1; -; mRNA.
DR   RefSeq; NP_955413.1; NM_199381.1.
DR   RefSeq; XP_006235973.1; XM_006235911.3.
DR   RefSeq; XP_008760861.1; XM_008762639.2.
DR   RefSeq; XP_017448006.1; XM_017592517.1.
DR   AlphaFoldDB; Q769K2; -.
DR   SMR; Q769K2; -.
DR   STRING; 10116.ENSRNOP00000015322; -.
DR   SwissLipids; SLP:000001131; -.
DR   iPTMnet; Q769K2; -.
DR   PhosphoSitePlus; Q769K2; -.
DR   PaxDb; 10116-ENSRNOP00000015322; -.
DR   Ensembl; ENSRNOT00000116230.1; ENSRNOP00000082705.1; ENSRNOG00000011363.5.
DR   GeneID; 296757; -.
DR   KEGG; rno:296757; -.
DR   AGR; RGD:735197; -.
DR   CTD; 222236; -.
DR   RGD; 735197; Napepld.
DR   eggNOG; KOG3798; Eukaryota.
DR   GeneTree; ENSGT00390000017990; -.
DR   InParanoid; Q769K2; -.
DR   OrthoDB; 226459at2759; -.
DR   PhylomeDB; Q769K2; -.
DR   BRENDA; 3.1.4.54; 5301.
DR   PRO; PR:Q769K2; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000011363; Expressed in heart and 18 other cell types or tissues.
DR   ExpressionAtlas; Q769K2; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; ISO:RGD.
DR   GO; GO:0043227; C:membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0030868; C:smooth endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0032052; F:bile acid binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0070290; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; ISS:UniProtKB.
DR   GO; GO:0004620; F:phospholipase activity; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0048874; P:host-mediated regulation of intestinal microbiota composition; ISS:UniProtKB.
DR   GO; GO:0070291; P:N-acylethanolamine metabolic process; ISO:RGD.
DR   GO; GO:0070292; P:N-acylphosphatidylethanolamine metabolic process; ISS:UniProtKB.
DR   GO; GO:1903999; P:negative regulation of eating behavior; IMP:RGD.
DR   GO; GO:0009395; P:phospholipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:RGD.
DR   GO; GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0035900; P:response to isolation stress; IEP:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; ISS:UniProtKB.
DR   Gene3D; 3.60.15.10; Ribonuclease Z/Hydroxyacylglutathione hydrolase-like; 1.
DR   InterPro; IPR001279; Metallo-B-lactamas.
DR   InterPro; IPR024884; NAPE-PLD.
DR   InterPro; IPR036866; RibonucZ/Hydroxyglut_hydro.
DR   PANTHER; PTHR15032; N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; 1.
DR   PANTHER; PTHR15032:SF4; N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; 1.
DR   Pfam; PF12706; Lactamase_B_2; 1.
DR   PIRSF; PIRSF038896; NAPE-PLD; 1.
DR   SUPFAM; SSF56281; Metallo-hydrolase/oxidoreductase; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Endosome; Golgi apparatus;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Membrane; Metal-binding;
KW   Nucleus; Phospholipid degradation; Phospholipid metabolism;
KW   Reference proteome; Zinc.
FT   CHAIN           1..396
FT                   /note="N-acyl-phosphatidylethanolamine-hydrolyzing
FT                   phospholipase D"
FT                   /id="PRO_0000318162"
FT   REGION          1..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..15
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        22..39
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         185
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         187
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         188
FT                   /ligand="N-acyl-1,2-diacyl-sn-glycero-3-
FT                   phosphoethanolamine"
FT                   /ligand_id="ChEBI:CHEBI:62537"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         189
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         190
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         253
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         256
FT                   /ligand="deoxycholate"
FT                   /ligand_id="ChEBI:CHEBI:23614"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         284
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         284
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         321
FT                   /ligand="N-acyl-1,2-diacyl-sn-glycero-3-
FT                   phosphoethanolamine"
FT                   /ligand_id="ChEBI:CHEBI:62537"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         343
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   BINDING         348
FT                   /ligand="deoxycholate"
FT                   /ligand_id="ChEBI:CHEBI:23614"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6IQ20"
FT   MUTAGEN         147
FT                   /note="D->N: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         170
FT                   /note="C->S: Small decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         185
FT                   /note="H->N: <1% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         187
FT                   /note="H->N: <1% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         189
FT                   /note="D->N: <1% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         190
FT                   /note="H->N: <1% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         207
FT                   /note="L->F: <5% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         222
FT                   /note="C->S: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         224
FT                   /note="C->S: Considerable decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         237
FT                   /note="C->S: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         253
FT                   /note="H->N: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         255
FT                   /note="C->S: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         284
FT                   /note="D->N: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         288
FT                   /note="C->S: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         321
FT                   /note="H->N: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         331
FT                   /note="H->N: 4% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         343
FT                   /note="H->N: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         353
FT                   /note="H->N: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
FT   MUTAGEN         380
FT                   /note="H->R: <5% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:16527816"
SQ   SEQUENCE   396 AA;  45723 MW;  57AD6EC8B2C7363F CRC64;
     MDENENSQSP APSHQYPKET LRKRQNSVQN SGGSESSRLS RKSFKLDYRL EEDVTKSKKG
     KDGRFVNPWP TWKNVSIPNV LRWLIMEKDH SSVPGSKEEL DKELPVLKPY FISDPEEAGV
     REAGLRVTWL GHATLMVEMD ELILLTDPMF SSRASPSQYM GPKRFRRPPC TISELPPIDA
     VLISHNHYDH LDYGSVLALN ERFGSELRWF VPLGLLDWMQ KCGCENVIEL DWWEENCVPG
     HDKVTFVFTP SQHWCKRTLL DDNKVLWGSW SVLGPWNRFF FAGDTGYCPA FEEIGKRFGP
     FDLAAIPIGA YEPRWFMKYQ HADPEDAVRI HIDVQAKRSV AIHWGTFALA NEHYLEPPVK
     LNEALERYGL KSEDFFILKH GESRYLNTDD KAFEET
//
